SynGAP Research Fund Strategic Roadmap Toward Therapeutics (IMAGE)

Syngap Research Fund

SynGAP Research Fund Strategic Roadmap Toward Therapeutics

Caption

This roadmap illustrates the strategic evolution of the SynGAP Research Fund (SRF) from its founding in 2019 to its current focus on therapeutic readiness, biomarker development, and clinical trial infrastructure for SYNGAP1-related disorder. Milestones include ICD-10 coding, biomarker research, grant funding, and international partnerships.

Credit

SynGAP Research Fund

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.